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Introduction
>50% PDAs 
registered in the 
Decision Aid Library 
Inventory have some 
form of Internet 
function (Hoffman, 
2013)
Expert consensus of web-based PDAs : 
Additional studies are needed to 
test how web-specific features 
(e.g. audio voice-overs, interactive 
graphics, touch-screen data entry) 
impact patients’ decision making 
(Hoffman, 2013)
Setting: Malaysia
• Dual-healthcare system
• Multi-cultural society
• Middle-income
• 67.8% of households were connected to the Internet in 2014
• 1/3 of users used the Internet to look for health-related information
• Insulin use is poor; T2DM prevalence at 16.6% (IDF 2014), insulin use 
at 7.2% (vs 36% in the US) (Letchuman 2010; CDC 2009)
Aim
•To evaluate the utility of the “Should I Start 
Insulin?” web-based PDA
• impact on decision process
Website development
Content
• Needs assessment 
(interviews)
• Literature review
• IPDAS Quality Checklist
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Website 
sections
• Diabetes and insulin
• Concerns about insulin
• Blood sugar and risk
• Treatment options
• Knowing your priority
• Support and decision
• Summary print-out
The website
6 Sections in the website
Methods 1: Website development
Content
• Needs 
assessment
• Literature 
review
• IPDAS Quality 
Checklist
Website 
sections
• Diabetes and insulin
• Concerns about insulin
• Blood sugar and risk
• Treatment options
• Knowing your priority
• Support and decision
• Summary print-out
Design 
features
• Animations
• Slide-by-slide scrolling
• Personalized HbA1c and 
complication risk charts
• Attribute selectable 
treatment options info
• Drag-and-drop concerns
Animations
Personalised HbA1c and 
complications risk chart
Methods: Utility testing
• Design: Qualitative, pragmatic methodology
• Sample: Patients with type 2 diabetes at the outpatient clinic of the 
University of Malaya Medical Centre (UMMC), Malaysia; advised to 
start insulin; English-literate; experience with IT
• Sampling: Convenience sampling at UMMC outpatient clinic
• Data collection: 
• Pre-post questionnaire (demographics, website usability and utility ratings)
• Retrospective think aloud: Computer screen movement + facial expressions 
recorded simultaneously interview on users’ views and experiences while 
watching playback 
Methods (continued)
• Website revision 
• Same-day field notes 
• Framework analysis based on interview 
• Research team consensus meeting 
• Cycle repeated until no major issues emerged (3 cycles)
Results
• Three rounds of website testing with 13 patients (n=6, 4, 3)
• Age: Median 65 years
• Gender: 10 men, 3 women
• Education level: 9 secondary/diploma, 4 graduate/postgraduate 
degree
Utility effect 1: Patient information
• Insulin-related knowledge increased
I’m not aware….Insulin may cause hypo. Yes I’ve taken some tablets 
and became hypo, so my concern is once you use insulin, you might 
become hypo.     Patient B, Cycle 1
• Personalized blood sugar control trend and complications risk chart helped them 
understand their risk
This is very informative, like now I immediately, in my case I can see 
the 32% get complications, so I’m still in the safe zone (laughs). 
Patient B, Cycle 1
At least you can highlight are you at the dangerous zone or moderate 
(talking about HbA1c trend chart). You know where you stand.
Patient O, Cycle 1
Utility effect 2: Deliberating between options
Patient-selectable 
attributes
Utility effect 2: Deliberating between options
Utility effect 2: Deliberating between options
• Clarifying which options were available (elimination)
It helped me to understand that I need insulin as I have taken 
maximum oral tablets.
Patient C, Cycle 3
• Felt the website was biased towards insulin
I think you are trying to persuade me to start insulin. Most of the 
information are towards that. 
Patient N, Cycle 2
Utility effect 2: Deliberating between options
• The combination of Hba1c chart, the complication risk chart and the 
weighing scales of their values formed an evidence base for decisions
I think, the HbA1c chart, my risk and the weighing scales...gives 
me a  summary of my results. [So I am clear] on certain terms, 
based on my result, why I should start insulin. 
Patient W, Cycle 2
• Patients refusing insulin would reconsider
I have made up my mind (not to start insulin). But I learn quite a 
lot. The pics are quite scary. I think again I may consider starting 
insulin. But not now.
Patient N, Cycle 2
Utility effect 3: Involving others in 
the decision
• With family: Share the website with them
Frankly speaking, my wife will say “No, why do you want to go on insulin, it’s so 
troublesome”. They think its best you can do without it… You see you need to 
make the next person to understand that you need insulin.
Patient G, Cycle 1
• With HCP: Show the summary to the doctor
I would keep (the pdf summary) for reference and show to the doctor and 
discuss.
Patient C, Cycle 3
Discussion
•Personalized view of risk information
• Simple rule-based risk score
• the HbA1c chart and personalized information on risk
patients view it as their personal risk. 
• Elaboration Likelihood Model 
• people pay attention, actively process information more if seen 
as personally-relevant (Petty and Cacioppo 1990, Hoffman, Volk 
et al. 2013). 
• But…felt they were being persuaded
Discussion
• Matrix-selectable options for options information
• 6 (options) x 7 (attributes) = 42 item matrix
• Strategy: allowing patients to select the attributes of interest to them, and 
screening out unnecessary options beforehandMatrix reduced
• More precise focus on their own information needs, less information to digest
• More studies are required on adapting other preference-based PDA 
sections (e.g. patient values elicitation) to web-based formats 
Conclusion
• Interactive web functions provided tailored information according to 
patient preferences. 
• This helped patients feel engaged with the information presented to 
them and they used this information when making a decision. 
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